MATTHEW VOOK: Open Payments
NPI 1316677156 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 27 payments from 14 companies in 2025. Trend: 2023 $1,788 · 2024 $1,245 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 1 | $120 |
| PFIZER INC. | 6 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| Exact Sciences Corporation | 2 | $58 |
| Amgen Inc. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Astellas Pharma US Inc | 2 | $38 |
| ABBVIE INC. | 2 | $33 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $28 |
Products named: UPTRAVI, Kerendia, PREVNAR 20, The Cologuard Plus Collection Kit, NURTEC ODT, Veozah, EVENITY, CAPVAXIVE.
Industry payments across MD — which companies pay providers there.
